Pancreatic Adenocarcinoma
1 competing product in clinical development for Pancreatic Adenocarcinoma.
Pipeline by Phase
Phase 1/21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Ramucirumab | Eli Lilly | Phase 1/2 | Completed | 41 |
1 competing product in clinical development for Pancreatic Adenocarcinoma.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Ramucirumab | Eli Lilly | Phase 1/2 | Completed | 41 |